348 Defining T cell recognition of a highly conserved fusion neoantigen in fibrolamellar carcinoma
Allison M. Kirk(St. Jude Children's Research Hospital), Paul Thomas(University of California, Berkeley), Scott E. Strome(Northwestern Medicine Lake Forest Hospital), Christopher DeRenzo(St. Jude Children's Research Hospital), Anthony E. Zamora(Medical College of Wisconsin), Ching‐Heng Chou(St. Jude Children's Research Hospital), Walid H. Awad, Xiaoyu Zhang(Minzu University of China), Phuong L. Nguyen(St. Jude Children's Research Hospital), Jeremy Chase Crawford(St. Jude Children's Research Hospital), E. Kaitlynn Allen(University of Virginia)
Cited by 0
Related Papers
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
|The Journal of Experimental Medicine|2004|1.8k
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
|Proceedings of the National Academy of Sciences|2004|767
Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|548